-
Postop Anxiety During Care Transitions Reduced With Peer Mentoring
drugs.com
January 28, 2022
Mentoring programs can help improve patients' transition from hospital to home by reducing...
-
FDA: Blood Clot, Death Risk Up With Higher Dose of Tofacitinib
drugs
July 29, 2019
New warnings about an increased risk of thrombosis and of death among ulcerative colitis patients taking the 10 mg twice daily dose of the drug tofacitinib...
-
PMZ-1620 Enters Phase III Trial in Patients with Cerebral Ischemic Stroke
americanpharmaceuticalreview
July 22, 2019
Pharmazz has received permission to initiate a prospective, multicentric, randomized, double-blind, parallel, phase III clinical study to assess efficacy of PMZ-1620 along with standard treatment in patients of acute ischemic stroke in India.
-
Many Patients Don't Need Opioids After Surgery
drugs
June 04, 2019
Many patients don't need opioids after surgery.
-
Cancer Patients Vaping in Growing Numbers
drugs
May 31, 2019
Vaping is gaining a foothold in an unlikely population: New research shows a growing number of cancer patients are using electronic cigarettes.
-
British Columbia first province to switch patients to biosimilars
europeanpharmaceuticalreview
May 31, 2019
British Columbia has said it will switch as many as 20,400 patients from three branded biologic drugs to cheap biosimilars.
-
British Columbia in Canada switches patients to biosimilars
pharmaceutical-technology
May 30, 2019
British Columbia (BC) has revealed plans to switch certain patients under public drug programme PharmaCare from biologics to biosimilars.
-
Aspirin green light for brain bleed stroke patients, study finds
worldpharmanews
May 24, 2019
People who suffer a stroke caused by bleeding in the brain - known as brain haemorrhage - can take common medicines without raising their risk of another stroke, a major clinical trial has found.
-
‘Record’ number of patients taking part in clinical trials
pharmatimes
May 20, 2019
The National Institute for Health Research (NIHR) has announced that a record number of patients are now taking part in clinical trials.
-
Varian partners with Proton Therapy
biospectrumasia
May 15, 2019
This installation marks a key milestone for the first proton therapy center in Singapore, ASEAN, Australia and New Zealand.